Ambrisentan for pulmonary arterial hypertension: Long term effects on clinical status, exercise capacity and haemodynamics

International Journal of Cardiology

Volumn 156, Issue 2, 2012, Pages 244-245

  D'Alto, Michele ^a   Romeo, Emanuele ^a   Argiento, Paola ^a   Correra, Anna ^a   Sarubbi, Berardo ^a   Scognamiglio, Giancarlo ^a   Grimaldi, Nicola ^a   Pignatiello, Maria ^a   Calabrò, Raffaele ^a   Russo, Maria G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Haemodynamics; Pulmonary arterial hypertension; Therapy

Indexed keywords

AMBRISENTAN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL PRESSURE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEADACHE; HEART CATHETERIZATION; HEART INDEX; HUMAN; LETTER; LUNG VASCULAR RESISTANCE; MALE; MEDICAL HISTORY; NOSE CONGESTION; OPEN STUDY; OXYGEN SATURATION; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SEROLOGY; SIDE EFFECT; SINGLE BLIND PROCEDURE; WALKING;

EID: 84858284543     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.01.054     Document Type: Article

References (7)

1. N. Galié, H. Olschewski, and R.J. Oudiz Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2 Circulation 117 2008 3010 3019
2. N. Galiè, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Heart J 30 2009 2493 2537
3. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2
4. P.L. Enright, and D.L. Sherrill Reference equations for the six-minute walk in healthy adults Am J Respir Crit Care Med 158 1998 1384 1387
5. S.E. Blalock, S. Matulevicius, and L.C. Mitchell Long-term outcomes with ambrisentan monotherapy in pulmonary arterial hypertension J Card Fail 16 2010 121 127
6. J.R. Klinger, R.J. Oudiz, R. Spence, D. Despain, and C. Dufton Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension Am J Cardiol 108 2011 302 307
7. R.J. Oudiz, N. Galiè, and H. Olschewski ARIES Study Group. Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension J Am Coll Cardiol 54 2009 1971 1981